A pretreatment nomogram for prediction of biochemical failure after primary cryoablation of the prostate

Ahmed Elshafei, Evan Z. Kovac, Nivedita Dhar, David Levy, Thomas Polascik, Vladimir Mouraviev, Changhong Yu, J. Stephen Jones

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background To create a predictive nomogram for biochemical failure following primary whole-gland cryoablation of the prostate for localized prostate cancer (LPCa). Methods We retrospectively analyzed 2,242 patients from the Cryo On-Line Database (COLD) who were treatment naive and had undergone primary whole gland cryoablation of the prostate for biopsy-confirmed LPCa. Kaplan-Meier (KM) curves estimating 5 year biochemical progression-free survival (bPFS) were generated. Multivariable Cox proportional hazards analysis (CoxPH) was performed in order to construct the nomogram. The nomogram was internally validated using the bootstrap technique. Results Overall, the KM estimated 5 year bPFS was 72.8%. Stratified by D'Amico risk, The KM estimated 5 year bPFS was 82.6%, 71.1%, and 57.8% for low-, intermediate-, and high-risk groups, respectively. Statistically significant predictors of biochemical outcomes from CoxPH analysis were pre-treatment prostate specific antigen (PTPSA) (P-<-0.001), total prostate volume (P-=-0.004), clinical stage (P-=-0.034), and Gleason score (0.004). A nomogram for predicted 5 year biochemical progression free probability was constructed with a concordance index of 0.652. An online risk calculator was also generated. Conclusions To the best of our knowledge, this is the first predictive nomogram for biochemical outcomes after primary whole gland cryoablation of the prostate using socio-demographic, pretreatment, clinical, and prostate biopsy data. Our nomogram and online risk calculator can guide both patients and urologists for shared decision making regarding definitive treatment options.

Original languageEnglish (US)
Pages (from-to)1447-1453
Number of pages7
JournalProstate
Volume75
Issue number13
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Nomograms
Cryosurgery
Prostate
Disease-Free Survival
Prostatic Neoplasms
Biopsy
Neoplasm Grading
Prostate-Specific Antigen
Decision Making
Therapeutics
Demography
Databases

Keywords

  • biochemical progression free survival
  • low grade prostate cancer
  • nomogram

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Elshafei, A., Kovac, E. Z., Dhar, N., Levy, D., Polascik, T., Mouraviev, V., ... Jones, J. S. (2015). A pretreatment nomogram for prediction of biochemical failure after primary cryoablation of the prostate. Prostate, 75(13), 1447-1453. https://doi.org/10.1002/pros.23030

A pretreatment nomogram for prediction of biochemical failure after primary cryoablation of the prostate. / Elshafei, Ahmed; Kovac, Evan Z.; Dhar, Nivedita; Levy, David; Polascik, Thomas; Mouraviev, Vladimir; Yu, Changhong; Jones, J. Stephen.

In: Prostate, Vol. 75, No. 13, 01.01.2015, p. 1447-1453.

Research output: Contribution to journalArticle

Elshafei, A, Kovac, EZ, Dhar, N, Levy, D, Polascik, T, Mouraviev, V, Yu, C & Jones, JS 2015, 'A pretreatment nomogram for prediction of biochemical failure after primary cryoablation of the prostate', Prostate, vol. 75, no. 13, pp. 1447-1453. https://doi.org/10.1002/pros.23030
Elshafei, Ahmed ; Kovac, Evan Z. ; Dhar, Nivedita ; Levy, David ; Polascik, Thomas ; Mouraviev, Vladimir ; Yu, Changhong ; Jones, J. Stephen. / A pretreatment nomogram for prediction of biochemical failure after primary cryoablation of the prostate. In: Prostate. 2015 ; Vol. 75, No. 13. pp. 1447-1453.
@article{b5fca1aacc9745dfba4060fb98b734da,
title = "A pretreatment nomogram for prediction of biochemical failure after primary cryoablation of the prostate",
abstract = "Background To create a predictive nomogram for biochemical failure following primary whole-gland cryoablation of the prostate for localized prostate cancer (LPCa). Methods We retrospectively analyzed 2,242 patients from the Cryo On-Line Database (COLD) who were treatment naive and had undergone primary whole gland cryoablation of the prostate for biopsy-confirmed LPCa. Kaplan-Meier (KM) curves estimating 5 year biochemical progression-free survival (bPFS) were generated. Multivariable Cox proportional hazards analysis (CoxPH) was performed in order to construct the nomogram. The nomogram was internally validated using the bootstrap technique. Results Overall, the KM estimated 5 year bPFS was 72.8{\%}. Stratified by D'Amico risk, The KM estimated 5 year bPFS was 82.6{\%}, 71.1{\%}, and 57.8{\%} for low-, intermediate-, and high-risk groups, respectively. Statistically significant predictors of biochemical outcomes from CoxPH analysis were pre-treatment prostate specific antigen (PTPSA) (P-<-0.001), total prostate volume (P-=-0.004), clinical stage (P-=-0.034), and Gleason score (0.004). A nomogram for predicted 5 year biochemical progression free probability was constructed with a concordance index of 0.652. An online risk calculator was also generated. Conclusions To the best of our knowledge, this is the first predictive nomogram for biochemical outcomes after primary whole gland cryoablation of the prostate using socio-demographic, pretreatment, clinical, and prostate biopsy data. Our nomogram and online risk calculator can guide both patients and urologists for shared decision making regarding definitive treatment options.",
keywords = "biochemical progression free survival, low grade prostate cancer, nomogram",
author = "Ahmed Elshafei and Kovac, {Evan Z.} and Nivedita Dhar and David Levy and Thomas Polascik and Vladimir Mouraviev and Changhong Yu and Jones, {J. Stephen}",
year = "2015",
month = "1",
day = "1",
doi = "10.1002/pros.23030",
language = "English (US)",
volume = "75",
pages = "1447--1453",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "13",

}

TY - JOUR

T1 - A pretreatment nomogram for prediction of biochemical failure after primary cryoablation of the prostate

AU - Elshafei, Ahmed

AU - Kovac, Evan Z.

AU - Dhar, Nivedita

AU - Levy, David

AU - Polascik, Thomas

AU - Mouraviev, Vladimir

AU - Yu, Changhong

AU - Jones, J. Stephen

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Background To create a predictive nomogram for biochemical failure following primary whole-gland cryoablation of the prostate for localized prostate cancer (LPCa). Methods We retrospectively analyzed 2,242 patients from the Cryo On-Line Database (COLD) who were treatment naive and had undergone primary whole gland cryoablation of the prostate for biopsy-confirmed LPCa. Kaplan-Meier (KM) curves estimating 5 year biochemical progression-free survival (bPFS) were generated. Multivariable Cox proportional hazards analysis (CoxPH) was performed in order to construct the nomogram. The nomogram was internally validated using the bootstrap technique. Results Overall, the KM estimated 5 year bPFS was 72.8%. Stratified by D'Amico risk, The KM estimated 5 year bPFS was 82.6%, 71.1%, and 57.8% for low-, intermediate-, and high-risk groups, respectively. Statistically significant predictors of biochemical outcomes from CoxPH analysis were pre-treatment prostate specific antigen (PTPSA) (P-<-0.001), total prostate volume (P-=-0.004), clinical stage (P-=-0.034), and Gleason score (0.004). A nomogram for predicted 5 year biochemical progression free probability was constructed with a concordance index of 0.652. An online risk calculator was also generated. Conclusions To the best of our knowledge, this is the first predictive nomogram for biochemical outcomes after primary whole gland cryoablation of the prostate using socio-demographic, pretreatment, clinical, and prostate biopsy data. Our nomogram and online risk calculator can guide both patients and urologists for shared decision making regarding definitive treatment options.

AB - Background To create a predictive nomogram for biochemical failure following primary whole-gland cryoablation of the prostate for localized prostate cancer (LPCa). Methods We retrospectively analyzed 2,242 patients from the Cryo On-Line Database (COLD) who were treatment naive and had undergone primary whole gland cryoablation of the prostate for biopsy-confirmed LPCa. Kaplan-Meier (KM) curves estimating 5 year biochemical progression-free survival (bPFS) were generated. Multivariable Cox proportional hazards analysis (CoxPH) was performed in order to construct the nomogram. The nomogram was internally validated using the bootstrap technique. Results Overall, the KM estimated 5 year bPFS was 72.8%. Stratified by D'Amico risk, The KM estimated 5 year bPFS was 82.6%, 71.1%, and 57.8% for low-, intermediate-, and high-risk groups, respectively. Statistically significant predictors of biochemical outcomes from CoxPH analysis were pre-treatment prostate specific antigen (PTPSA) (P-<-0.001), total prostate volume (P-=-0.004), clinical stage (P-=-0.034), and Gleason score (0.004). A nomogram for predicted 5 year biochemical progression free probability was constructed with a concordance index of 0.652. An online risk calculator was also generated. Conclusions To the best of our knowledge, this is the first predictive nomogram for biochemical outcomes after primary whole gland cryoablation of the prostate using socio-demographic, pretreatment, clinical, and prostate biopsy data. Our nomogram and online risk calculator can guide both patients and urologists for shared decision making regarding definitive treatment options.

KW - biochemical progression free survival

KW - low grade prostate cancer

KW - nomogram

UR - http://www.scopus.com/inward/record.url?scp=84939142048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939142048&partnerID=8YFLogxK

U2 - 10.1002/pros.23030

DO - 10.1002/pros.23030

M3 - Article

VL - 75

SP - 1447

EP - 1453

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 13

ER -